In emergencies, controlling the blood loss from a wound can be critical. Joe Landolina of Cresilon shares the progress being made with hemostatic gel that can stop the bleeding in seconds rather than traditional closures which take minutes. He will also highlight the potential for this technology to impact multiple, important industries.
* If you are having technical difficulties viewing the video please try different internet browsers like Chrome, Firefox, and Explorer. If you still can not access the video please review the following computer prerequisites from our video hosting platform.
What You Will Learn
- Novel biomaterial designed for hemostasis
- In vitro/in vivo testing of biomaterials
- Clinical applications of biomaterials
Additonal Resources
- "Don't Lose Sight of Opportunities: Navigating a Biotech Niche" - Article by Joe Landolina
- Bloomberg/Businessweek short video
;void(0);){kind=link}